0
Détail de l'éditeur
European Respiratory Society (ERS)
Collections rattachées :
|
Documents disponibles chez cet éditeur (31)
Ajouter le résultat dans votre panier Affiner la recherche
Light-emitting diode fluorescence microscopy for tuberculosis diagnosis: a meta-analysis / Eva W. Chang (2016)
Titre : Light-emitting diode fluorescence microscopy for tuberculosis diagnosis: a meta-analysis Type de document : document électronique Auteurs : Eva W. Chang, Auteur ; Anne-Laure Page, Auteur ; Maryline Bonnet, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. 47 Importance : p.929-937 Langues : Anglais (eng) Catégories : [TUBER] diagnostic
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 5. Méthodes de diagnostic En ligne : https://doi.org/10.1183/13993003.00978-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9434 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Lung function predicts lung cancer risk in smokers : a tool for targeting screening programmes Type de document : texte imprimé Auteurs : E. Calabro, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 35 (1) Importance : p.146-151 Langues : Anglais (eng) Catégories : [TABAC] tabagisme:pathologie:cancer:cancer du poumon
[TABAC] tabagisme:pathologie:cancer:dépistage
[TABAC] tabagisme:risque:facteur associé
[TABAC] tabagisme:tabagisme actif:fumeurIndex. décimale : TA 3.2.2.3 Cancer Résumé : The relationship between smoking, lung cancer and airflow obstruction is recognised but it is unclear whether the presence of minimal lung function damage constitutes an independent risk factor for the development of lung cancer. In order to identify those individuals at higher risk of lung cancer on the basis of functional impairment, we evaluated baseline pulmonary function tests of 3,806 heavy smokers undergoing annual chest computed tomography screening, and compared the forced expiratory volume in 1 s (FEV1) % predicted of 57 lung cancer cases and that of 3,749 subjects without cancer. We obtained odds ratios (ORs) of lung cancer and the corresponding 95% confidence intervals (CIs) using unconditional logistic regression, adjusting for age, sex, study and smoking variables. Compared with subjects with FEV1 ?90% pred, the OR of lung cancer was 2.45 (95% CI 1.39–4.33) for subjects with FEV1 <90% pred and 2.90 (95% CI 1.34–6.27) for subjects with FEV1 <70% pred. These data show that even a relatively small reduction in FEV1 % pred is a significant predictor of increased lung cancer risk. Test screening for lung cancer using airflow obstruction with FEV1 <90% is a strategy worth future consideration. En ligne : https://erj.ersjournals.com/content/35/1/146.long Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2704 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Lung transplantation / A.J. Fisher (2009)
Titre : Lung transplantation Type de document : texte imprimé Auteurs : A.J. Fisher, Auteur ; G.M. Verleden, Auteur ; G. Massard, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Monographs num. 45 Importance : 269 p. ISBN/ISSN/EAN : 978-1-904097-71-6 Langues : Anglais (eng) Catégories : [DIVERS] anatomie:corps humain:appareil respiratoire:poumon
[TABAC] tabagisme:risque:facteur associé:chirurgieIndex. décimale : TA 3.2.2.4 Pathologies respiratoires (sauf 3.2.2.1, 3.2.2.2, 3.2.2.3) Résumé : Lung transplantation is a treatment option for selected patients who are not responding to maximal medical therapy, or for whom no effective medical therapy exists. This book provides a comprehensive guide to the recent advances in lung transplantation, and includes coverage of donor selection, immunosuppression, infectious and noninfectious complications, and management of bronchiolitis obliterans syndrome and post-transplant lymphoproliferative disease emerging after lung transplantation. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1867 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002476 TA 3.2.2.4 FIS L Monographie Bibliothèque FARES Tabac Disponible Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe / Christoph Lange (2014)
Titre : Management of patients with multidrugresistant/ extensively drug-resistant tuberculosis in Europe : a TBNET consensus statement Type de document : document électronique Auteurs : Christoph Lange, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2014 Collection : European Respiratory Journal num. 44 Importance : p.23-63 Langues : Français (fre) Catégories : [DIVERS] géographie:Europe
[TUBER] prévention:recommandation
[TUBER] traitement:résistance:multirésistance:extrarésistanceIndex. décimale : TU 3.2. MDR (Multi Drug Resistance) / XDR (X-treme Drug Resistance) En ligne : 10.1183/09031936.00188313 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9390 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Maternal smoking during pregnancy induces airway remodelling in mice offspring / M.J. Blacquière (2009)
Titre : Maternal smoking during pregnancy induces airway remodelling in mice offspring Type de document : texte imprimé Auteurs : M.J. Blacquière, Auteur ; W. Timens, Auteur ; B.N. Melgert, Auteur ; M. Geerlings, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Journal num. 33 Importance : p. 1133-1140 Présentation : graph., photos, schéma Langues : Anglais (eng) Catégories : [TABAC] tabagisme:tabagisme actif:tabagisme féminin:tabagisme durant la grossesse Index. décimale : TA 3.2.2.7 Grossesse et fœtus Résumé : Children from smoking mothers have an increased risk of developing asthma for reasons largely unknown. The effects of maternal smoking during pregnancy on remodelling, allergic airway inflammation and hyperresponsiveness in offspring were investigated in an experimental asthma model. Mice were exposed to fresh air or cigarette smoke from 3 weeks prior to conception until birth. Offspring were exposed to house dust mite (HDM) or PBS intranasally four times per week from week 5 to week 10 after birth onwards. Maternal smoking increased airway smooth muscle layer, collagen III deposition and HDM-induced goblet cell numbers in offspring. It additionally increased methacholine responsiveness, which correlated significantly with increased airway smooth muscle layer and collagen deposition. Maternal smoking increased HDM-induced numbers of neutrophils and mast cells in lung tissue. No further effects were observed. Smoking during pregnancy induces airway remodelling in mice offspring, which may contribute to increased methacholine responsiveness. This takes place irrespective of allergen exposure but may worsen the outcome of the allergic stimulus, resulting in higher methacholine responsiveness in house dust mite-exposed offspring from smoking mothers when compared to nonsmoking mothers. The results provide a possible mechanism behind the association between maternal smoking and asthma. En ligne : https://erj.ersjournals.com/content/33/5/1133.long Format de la ressource électronique : HTML Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8055 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lung / G.J. Gaschler (2010)
Titre : Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lung Type de document : texte imprimé Auteurs : G.J. Gaschler, Auteur ; C.C.J. Zavitz, Auteur ; C.M.T. Bauer, Auteur ; M.R. Stämpfli, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2010 Collection : European Respiratory Journal num. 36 Importance : p. 1131-1142 Présentation : graph. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée
[TABAC] tabagisme:pathologie:pathologie respiratoire:broncho-pneumopathie chronique obstructiveIndex. décimale : TA 3.2.2.1 Expérimentation Résumé : Inflammation is prevalent in all stages of chronic obstructive pulmonary disease, and, furthermore, individuals undergo periods of exacerbation, during which pulmonary inflammation increases, often a result of bacterial infection. The present study investigates the in vivo consequences of cigarette smoke exposure on bacterial challenge with nontypeable Haemophilus influenzae (NTHi). BALB/c and C57 black 6 (C57BL/6) mice were exposed to cigarette smoke once or twice daily for a total period of 8 weeks. Exacerbated inflammation was observed in cigarette smoke-exposed compared to room-air-exposed mice following challenge with live or heat-inactivated NTHi. Accelerated clearance of live NTHi from cigarette smoke-exposed mice was independent of the establishment of chronic inflammation or direct toxic effects of cigarette smoke components on bacteria. Mechanistically, a cell-free factor in the bronchoalveolar lavage fluid contributed to accelerated clearance following passive transfer to naive mice. Further investigation demonstrated increased titres of immunoglobulin A in the bronchoalveolar lavage fluid, but not the blood, of cigarette smoke-exposed mice, including increased titres of NTHi-specific immunoglobulin A, whereas heavy chain joining element (J(H))(-/-) B-cell-deficient cigarette smoke-exposed mice did not demonstrate decreased bacterial burden following challenge. The present results demonstrate that cigarette smoke exposure results in exacerbated inflammation following challenge with NTHi, as well as increased titres of antibodies that contribute to bacterial clearance. En ligne : https://erj.ersjournals.com/content/36/5/1131 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8074 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005625 TA 3.2.2.1 GAS M Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Mefloquine as a potential drug against multidrug-resistant tuberculosis Type de document : document électronique Auteurs : David Krieger, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2015 Collection : European Respiratory Journal num. Vol 58 Issue 4 Importance : 3 p. Présentation : tab. Langues : Anglais (eng) Catégories : [TUBER] traitement
[TUBER] traitement:résistance:multirésistanceIndex. décimale : TU 3.2. MDR (Multi Drug Resistance) / XDR (X-treme Drug Resistance) En ligne : https://www.doi.org/10.1183/13993003.00321-2015 Format de la ressource électronique : Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9414 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Monitoring latent tuberculosis infection diagnosis and management in the Netherlands / C.G.M. Erkens (2016)
Titre : Monitoring latent tuberculosis infection diagnosis and management in the Netherlands Type de document : document électronique Auteurs : C.G.M. Erkens, Auteur ; E. Slump, Auteur ; Maurits Verhagen, Auteur ; H.J. Schimmel, Auteur ; Gerard de Vries, Auteur ; Frank Cobelens, Auteur ; Susan van den Hof, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. vol.47 nr 4 Importance : p.1492-1501 Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Pays-Bas
[TUBER] diagnostic
[TUBER] traitement
[TUBER] type de tuberculose:infection tuberculeuse latenteIndex. décimale : TU 2. Type de tuberculose et pathogies similaires Résumé : Targeted diagnosis and treatment of latent tuberculosis (TB) infection (LTBI) among persons with a high risk of exposure to TB or of developing TB when infected has been performed and monitored routinely in the Netherlands since 1993. We describe trends in target groups, diagnostic methods and treatment regimens, and explore determinants for treatment initiation, treatment completion and adverse events.
In total, 37 729 persons were registered with LTBI from 1993 to 2013, of whom 28 931 (77%) started preventive treatment; 82% of those completed preventive treatment and 8% stopped preventive treatment due to adverse events. Two-thirds of the notified cases were detected through contact investigation.
Increasing numbers of persons with immunosuppressive disorders, elderly persons and foreign-born persons were notified in recent years, due to policy changes and the introduction of the interferon-γ release assay. Children (96%) and the immunosuppressed (95%) were more likely to start preventive treatment. Children (93%) were also more likely to complete preventive treatment, as were persons treated with rifampicin or rifampicin/isoniazid regimens (91% and 92%, respectively). The latter groups were also 40% less likely to stop preventive treatment due to adverse events.
Under these operational conditions, the estimated risk reduction on incident TB in the target population for LTBI management is 40–60%.En ligne : https://doi.org/10.1183/13993003.01397-2015 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10153 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by humain airway smooth muscle cells / R. Gosens (2009)
Titre : Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by humain airway smooth muscle cells Type de document : texte imprimé Auteurs : R. Gosens, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2009 Collection : European Respiratory Journal num. 34 (6) Importance : p.1436-1443 Langues : Anglais (eng) Catégories : [TABAC] tabagisme:effet du tabac
[TABAC] tabagisme:tabagisme actifIndex. décimale : TA 3.2.2.6 Effets métaboliques et biologiques Résumé : Acetylcholine is the primary parasympathetic neurotransmitter in the airways and is known to cause bronchoconstriction and mucus secretion. Recent findings suggest that acetylcholine also regulates aspects of remodelling and inflammation through its action on muscarinic receptors. In the present study, we aimed to determine the effects of muscarinic receptor stimulation on cytokine production by human airway smooth muscle cells (primary and immortalised cell lines). The muscarinic receptor agonists carbachol and methacholine both induced modest effects on basal interleukin (IL)-8 and -6 secretion, whereas the secretion of RANTES, eotaxin, vascular endothelial growth factor-A and monocyte chemoattractant protein-1 was not affected. Secretion of IL-8 and -6 was only observed in immortalised airway smooth muscle cells that express muscarinic M3 receptors. In these cells, methacholine also significantly augmented IL-8 secretion in combination with cigarette smoke extract in a synergistic manner, whereas synergistic effects on IL-6 secretion were not significant. Muscarinic M3 receptors were the primary subtype involved in augmenting cigarette smoke extract-induced IL-8 secretion, as only tiotropium bromide and muscarinic M3 receptor subtype selective antagonists abrogated the effects of methacholine. Collectively, these results indicate that muscarinic M3 receptor stimulation augments cigarette smoke extract-induced cytokine production by airway smooth muscle. This interaction could be of importance in patients with chronic obstructive pulmonary disease. En ligne : https://erj.ersjournals.com/content/34/6/1436 Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2705 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
No added value of interferon-γ release to a prediction model for childhood tuberculosis / Toyin O. Togun (2016)
Titre : No added value of interferon-γ release to a prediction model for childhood tuberculosis Type de document : document électronique Auteurs : Toyin O. Togun, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. 47 Importance : p.223-232 Langues : Anglais (eng) Catégories : [DIVERS] personne:famille:enfant
[TUBER] diagnostic:test immunologique:test IGRAIndex. décimale : TU 3.4. Enfant En ligne : https://doi.org/10.1183/13993003.00890-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9423 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Old ideas to innovate tuberculosis control : preventive treatment to achieve elimination Type de document : document électronique Auteurs : Roland Diel, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2013 Collection : European Respiratory Journal num. 42 Importance : p.785-801 Langues : Anglais (eng) Catégories : [TUBER] prévention:stratégie Index. décimale : TU 3.1. Généralités En ligne : https://doi.org/10.1183/09031936.00205512 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9387 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Perinatal air pollution exposure and development of asthma from birth to age 10 years / Hind Sbihi (2016)
Titre : Perinatal air pollution exposure and development of asthma from birth to age 10 years Type de document : document électronique Auteurs : Hind Sbihi, Auteur ; Lillian Tamburic, Auteur ; Mieke Koehoorn, Auteur ; Michael Brauer, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. 47(4) Importance : p.1062-1071 Langues : Anglais (eng) Catégories : [DIVERS] personne:famille:enfant
[PROMOSAN] allergie:cause d'allergie:facteur aggravant:pollution
[PROMOSAN] asthme
[TABAC] tabagisme:effet sur l'environnement:pollution
[TABAC] tabagisme:pathologie:pathologie respiratoire:asthmeIndex. décimale : AA 1.6. Asthme chez l'enfant En ligne : https://doi.org/10.1183/13993003.00746-2015 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9431 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis / Sander P. van Rijn (2016)
Titre : Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis Type de document : document électronique Auteurs : Sander P. van Rijn, Auteur ; Richard van Altena, Auteur ; Onno W. Akkerman, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2016 Collection : European Respiratory Journal num. vol.47 nr 4 Importance : p. 1229-1234 Présentation : graph. Langues : Anglais (eng) Catégories : [TUBER] étude
[TUBER] traitement:résistanceIndex. décimale : TU 8.5.1. MDR (Multi Drug Resistance / XDR (X-treme Drug Resistance) Résumé : Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is becoming more challenging because of increased levels of drug resistance against second-line TB drugs. One promising group of antimicrobial drugs is carbapenems. Ertapenem is an attractive carbapenem for the treatment of MDR- and XDR-TB because its relatively long half-life enables once-daily dosing.
A retrospective study was performed for all patients with suspected MDR-TB at the Tuberculosis Center Beatrixoord of the University Medical Center Groningen (Haren, the Netherlands) who received ertapenem as part of their treatment regimen between December 1, 2010 and March 1, 2013. Safety and pharmacokinetics were evaluated.
18 patients were treated with 1000 mg ertapenem for a mean (range) of 77 (5–210) days. Sputum smear and culture were converted in all patients. Drug exposure was evaluated in 12 patients. The mean (range) area under the concentration–time curve up to 24 h was 544.9 (309–1130) h·mg·L−1. The mean (range) maximum observed plasma concentration was 127.5 (73.9–277.9) mg·L−1.
In general, ertapenem treatment was well tolerated during MDR-TB treatment and showed a favourable pharmacokinetic/pharmacodynamic profile in MDR-TB patients. We conclude that ertapenem is a highly promising drug for the treatment of MDR-TB that warrants further investigation.En ligne : https://www.doi.org/10.1183/13993003.01654-2015 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10149 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2 / G. De Cunto (2011)
Titre : Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2 Type de document : texte imprimé Auteurs : G. De Cunto, Auteur ; S. Cardini, Auteur ; G. Cirino, Auteur ; G. Lungarella, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2011 Collection : European Respiratory Journal num. 37 Importance : p.823-834 Présentation : tab., graph., ill. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:fumée
[TABAC] étudeIndex. décimale : TA 3.2.2.1 Expérimentation Résumé : The mechanism(s) involved in the development of pulmonary hypertension (PH) in COPD is still the object of investigation. Cigarette smoke (CS) may lead to remodelling of intrapulmonary vessels and dynamic changes in vascular function, at least in some smokers. A role for proteases in PH has been recently put forward. We investigated, in smoking mice, the role of protease-activated receptor (PAR)-2 in the pathogenesis of PH associated with emphysema. We demonstrated that CS exposure can modulate PAR-2 expression in mouse lung. Acute CS exposure induces in wildtype (WT) and in transgenic mice over-expressing PAR-2 (FVB(PAR-2-TgN)) a similar degree of neutrophil influx in bronchoalveolar lavage fluids. After chronic CS exposure WT and FVB(PAR-2-TgN) mice show emphysema, but only transgenic mice develop muscularisation of small intrapulmonary vessels that precedes the development of PH (~45% increase) and right ventricular hypertrophy. Smoking in FVB(PAR-2-TgN) mice results in an imbalance between vasoconstrictors (especially endothelin-1) and vasodilators (i.e. vascular endothelial growth factor, endothelial nitric oxide synthase and inducible nitric oxide synthase) and enhanced production of growth factors involved both in fibroblast-smooth muscle cell transaction (i.e. platelet-derived growth factor (PDGF) and transforming growth factor β) and vascular cell proliferation (PDGF). PAR-2 signalling can influence the production and release of many factors, which may play a role in the development of PH in smokers.
PMID: 20693251 DOI: 10.1183/09031936.00060210En ligne : https://erj.ersjournals.com/content/37/4/823.long Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8072 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Risk factors for the misdiagnosis of tuberculosis in the UK, 2001-2011 Type de document : document électronique Auteurs : Deborah Pedrazzoli, Auteur Editeur : European Respiratory Society (ERS) Année de publication : 2015 Collection : European Respiratory Journal num. 46 Importance : p.564-567 Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe:Europe occidentale:Royaume-Uni
[TUBER] diagnostic
[TUBER] type de tuberculose:tuberculose-maladieIndex. décimale : TU 5. Méthodes de diagnostic En ligne : www.doi.org/10.1183/09031936.00227914 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9403 Aucun avis, veuillez vous identifier pour ajouter le vôtre !